53 results
8-K
EX-3.1
COGT
Cogent Biosciences Inc
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
as a share of Series B Preferred Stock. Any share of Series B Preferred Stock so acquired shall, upon its retirement and cancellation, and upon the taking
8-K
EX-10.1
7ilr77e7 cczsm5ijx
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
8-K
EX-1.1
rpoax05
8 Jun 23
Entry into a Material Definitive Agreement
4:31pm
8-K/A
EX-1.1
n5bpkv 01dvv2ju9g
16 Jun 22
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-1.1
ui3ff93bhg5ot50
15 Jun 22
Entry into a Material Definitive Agreement
5:18pm